Fisher & Paykel Healthcare Corporation Limited (FPH.AX) Stock Analysis & Winston Score
Fisher & Paykel Healthcare makes medical devices that help people breathe. Its main products are machines and accessories used in hospitals to treat patients with breathing problems, including those with sleep apnea or respiratory illnesses like pneumonia. The company is based in New Zealand and is one of the leading makers of humidification systems — devices that warm and moisten the air delivered through breathing tubes and masks. The company sells its products to hospitals, clinics, and home care patients across more than 120 countries, with the United States being its largest market. It earns money through a mix of hardware sales and a recurring "razor-and-blades" model, where hospitals keep buying consumable accessories like masks, tubes, and chambers after the initial device purchase — this repeat-purchase cycle gives the business a durable revenue stream. The key growth driver is rising global demand for respiratory care, but the main risk is currency exposure, since most revenue is earned in US dollars while costs are largely in New Zealand dollars.
Winston Score: 58/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Exceptional (26/30)
- Growth: Mixed (5/20)
- Cash Flow: Exceptional (10/10)
- Stability: Exceptional (10/10)
- Valuation: Mixed (4/10)
- Ownership: Weak (2/15)



